Lanxess (LXS) Q2 2025 earnings summary

Executive summary

• Q2 2025 was marked by challenging market conditions, with lower volumes, weak demand, and high volatility, especially in automotive, capital goods, chemicals, agrochemical, and construction sectors.

• The completed sale of the Urethane Systems business unit in April 2025 contributed to significant net debt reduction and marked the exit from the polymer business.

• Strategic actions included plant closures, production optimization, and cost-saving initiatives targeting €50 million annual savings by 2027.

• EBITDA pre exceptionals fell to €150 million in Q2 2025, mainly due to portfolio changes and volume effects.

• Working capital remained stable, with improvements in receivables and inventory management.

Financial highlights

• Q2 2025 sales declined 12.6% year-over-year to €1,466 million; EBITDA pre exceptionals down 17.1% to €150 million.

• Net income for Q2 2025 was –€45 million, compared to –€16 million in Q2 2024.

• Free cash flow in Q2 2025 was €31 million, down from €83 million in Q2 2024.

• Net financial debt reduced to €2,069 million at end of Q2 2025, down from €2,512 million in Q1 2025.

• Gross margin improved to 22.3% in Q2 2025 (Q2 2024: 21.7%).

Outlook and guidance

• Full-year 2025 EBITDA pre exceptionals guidance lowered to €520–580 million, reflecting weak markets and a €10 million burden from chlorine supply restrictions.

• No demand recovery expected in H2 2025; Q3 EBITDA pre expected to be sequentially lower than Q2.

• Mildly positive outlook for Q4 as customers prepare for a potential demand pickup in 2026, with government stimulus and tariff stabilization expected to benefit the industry.